Nexium, like any medication, contains the active ingredient esomeprazole, which is a type of medication called a proton pump inhibitor (PPI).
On the bright side of the epathic route, esomeprazole is absorbed into the bloodstream and stimulates the acid pumps in the stomach. This leads to a reduced number of stomach acid production, which leads to a reduced symptoms of illness.
When taken as prescribed, esomeprazole is taken orally, and it can cause side effects like diarrhea or stomach pain. However, it is recommended to take it with a meal or snack as prescribed by your doctor. Do not take esomeprazole if you have had an asthma attack or other allergic reaction to it or any other PPI medication. Do not drink alcohol with esomeprazole.
To prevent the medication from leaking out, always follow your doctor’s instructions on how to store or pour the medication. Do not exceed the recommended dosage.
The usual dose is one tablet taken once or twice daily, depending on how many tablets are prescribed. However, your doctor may recommend a different starting dose if you are taking a higher dose medication.
The recommended dose for adults is one tablet taken once daily, regardless of the time of the day. Do not take a double dose to make up for a missed dose. If you are taking Nexium (esomeprazole), do not stop taking it without consulting your doctor first.
The most common side effects of Nexium (esomeprazole) are generally mild and go away on their own. However, if you experience any of these serious side effects, seek medical attention immediately:
If any of these side effects remain or worsen, seek medical attention immediately.
Salt Composition in both
Salt Composition
Esomeprazole 40mg(same for both)
You Searched
Strip of 14 tablets
We only sell the best substitute from top brands
Our Recommendation
Esopen 40mg Tablet 10s
Strip of 10 tablets
472+ Customers trust this
WHO GMP Certified
Marketed by
Doctor ApprovedMedicine Comparison
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Pantosec DSR 30/40mg PR Capsule 10sPantosec 40mg Tablet 10sCipvildin M 500/50mg Tablet 15sAb Rozu 10mg Tablet 10sCipcal D3 60000IU Capsule 4sCipcal 500mg/250IU Tablet 15sDapaquest 10mg Tablet 10sMontecip LC 5/10mg Tablet 10sLipvas 10mg Tablet 10sParacip 650mg Tablet 10sView More
Aerolife inhalation Device 1sAir Space Wit Exhle Valve Device 1sBp Monitor (Omron) Hem 8712 Device 1sContour Plus System 1sDigital Thermometer Mercury Device 1sDuohaler DPI Device 1sIbreathe DPI Inhealer Device 1sMachaler DPI Device 1sMacspacer Device 1sNovopen 4 | Diabetes Monitoring Devices 1s
Must be:To order this product, our medical team will need to 1) consult the feet Health team before choosing esomeprazole, 2) review the product, 2)yi it if appropriate and 3) buy it online from leading Wholesale PLC vendors. See the. Please also note that these vendors must be a within 28 hours ofaffiliated pharmacies to issue a pms. For more information, please see in store.
To order this product, our medical team will need to 1) consult the feet Health team before choosing esomeprazole, 2) review the product, 2)yi it if appropriate and 3) buy it online from leading vendors.
Alternate Name:Pharmapure RX Esomep-EZS
Description:Nexium treats gastroesophageal reflux disease (GERD), esophagitis, and stomach ulcers. The generic version of Nexium is esomeprazole magnesium. For a supply of 30 oral tablets of Nexium Delayed-Release Capsules 40 mg is approximately $287. Take advantage of our LowerMyRx discount to receive a typical Nexium discount of up to 80% off of the retail price at participating pharmacies near you.
Dosage Form:Capsule Delayed Release
Administration Route:By mouth
Drug Class:Gastric Acid Secretion Inhibitor, Gastrointestinal Agent
Generic Available:Yes
Strength:20 MG
Warnings:Tell your doctor if you are pregnant or breastfeeding, or if you have kidney disease, liver disease, lupus, vitamin B12 deficiency, or osteoporosis. This medicine may cause the following problems: Kidney problems, including acute tubulointerstitial nephritisIncreased risk of broken bones in the hip, wrist, or spine (more likely if used several times per day or longer than 1 year)Serious skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, and drug reaction with eosinophilia and systemic symptoms (DRESS)LupusFundic gland polyps (abnormal growth in the upper part of your stomach) This medicine can cause diarrhea. Call your doctor if the diarrhea becomes severe, does not stop, or is bloody. Do not take any medicine to stop diarrhea until you have talked to your doctor. Diarrhea can occur 2 months or more after you stop taking this medicine. Tell any doctor or dentist who treats you that you are using this medicine. This medicine may affect certain medical test results. Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments. Keep all medicine out of the reach of children. Never share your medicine with anyone. Stomach pain, nausea, vomiting, weight loss, bloody or black stools
Food Warnings:Do not use esomeprazole if you are also using medicines that contain rilpivirine., Some medicines can affect how esomeprazole works. Tell your doctor if you are using any of the following: Atazanavir, cilostazol, diazepam, digoxin, erlotinib, ketoconazole, methotrexate, mycophenolate mofetil, nelfinavir, rifampin, saquinavir, St John's wort, tacrolimus, voriconazoleBlood thinner (including clopidogrel or warfarin)Diuretic (water pill)Iron supplements, This medicine can cause diarrhea. Diarrhea can occur 2 months or more after you stop taking this medicine., Tell any doctor or dentist who treats you that you are using this medicine. This medicine may affect certain medical test results., Your doctor will check your progress and the effects of this medicine at regular visits. Keep all appointments., Keep all medicine out of the reach of children.
You should know how to tell the difference between diet and diet. Diet and diet. What to do if you have been told by your doctor that you have an intolerance to some sugarsThis medicine can cause the following problems: Kidney problems, including acute generalized eosinophilia and systemic symptoms (DRESS)Increased risk of broken bones in the hip, wrist or hands (more likely if used several times per day or longer than 1 year)Serious skin reactions, including Stevens-Johnson syndrome, toxic epidermal nephritis, and drug reaction with eosinophilia and systemic symptoms (DRESS)LupusFundic gland polyp (abnormal growth in the upper part of your stomach, especially in your upper stomach) This medicine can cause diarrhea.The Singapore Food and Drug Administration (FDA) has approved the first-of-its-kind approval of a new anti-inflammatory drug (NSAID) for chronic pain in adults.
The approval of a new drug for adults is a major step forward in the ongoing treatment of arthritis, the joint-related symptoms of rheumatoid arthritis and inflammatory conditions. This new indication will be used to treat chronic pain in adults with arthritis.
A Phase 3 trial that compared celecoxib with placebo in adults with arthritis treated with an NSAID for pain and the relief of symptoms, such as joint pain and swelling, is expected to be completed in the second half of 2019. The drug may be marketed in three forms (Nexium, Nucala and Singulair) for short-term use in the United States.
The study was sponsored by Eli Lilly and Company, which has agreed to pay $1.1 million to settle a class-action lawsuit filed by the plaintiffs in the class action lawsuit against the companies. The settlement agreement also includes a $250,000 settlement of $500,000 for the class action.
“We believe that the approval of a new drug for chronic pain in adults would be a significant milestone in the treatment of this potentially life-threatening condition,” said Dr. Steven Nissen, MD, chairman and chief executive officer of Eli Lilly and Company. “This decision represents a significant step forward in the development of a new indication for a new drug for chronic pain in adults.”
According to the FDA, the U. S. Food and Drug Administration (FDA) is the first to approve new anti-inflammatory drugs. The new indication for Nexium and Singulair is for relief of arthritis-related symptoms, such as joint pain.
Celecoxib has been the most widely-used NSAID in the U. for the past five years, generating worldwide sales of approximately $12.5 billion for the drug. Sales of the drug rose nearly 20% to $10.5 billion for the same period.
The new drug is expected to be marketed by AstraZeneca, a biopharmaceutical company that makes AstraZeneca's cholesterol-lowering drug Zetia. It is expected to be available in a second-generation drug approved by the FDA in June, which is being manufactured by Aventis, the company's own generic drugmaker. In addition, the company has made in-house research and development investments in the area of heart disease and asthma.
“We are excited about this opportunity to bring an innovative treatment to patients that will help them manage chronic pain effectively,” said Dr. David A. Heide, MD, vice president of global research for AstraZeneca. “We are pleased to be able to bring these new therapies to patients in a safe and effective manner.”
The new indication for Singulair is for relief of arthritis symptoms and the relief of joint pain in adults. The drug is marketed under the brand name Nexium for the treatment of arthritis, which is the most common form of arthritis worldwide.
Singulair is the first anti-inflammatory drug to be approved for pain in adults since COX-2 inhibitors were first approved by the FDA in 1975. In adults, it is prescribed as an over-the-counter drug to help relieve symptoms of arthritis and to reduce the risk of osteoarthritis.
The FDA approves a class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs) to treat arthritis pain. NSAIDs work by inhibiting an enzyme called cyclo-oxygenase (COX), which is involved in the production of prostaglandins. These protective substances help keep arthritis pain under control.
The new indication for Nexium is a treatment for acute pain in adults. The drug is approved for up to 6 months of treatment, which can last for up to 12 months.
Nexium is the second COX-2 inhibitor to be approved by the FDA for chronic pain in adults. COX-2 inhibitors block the body's ability to produce and release certain prostaglandins, which cause pain, inflammation and swelling in the joint. These prostaglandins play a crucial role in pain and fever.
“This approval demonstrates the significant potential of this new indication for chronic pain in adults,” said Dr. Edward D. Lechleiter, president and chief executive officer of Pfizer. “It demonstrates that we can provide a comprehensive treatment option for this important chronic pain that patients can access at convenient times and be able to take advantage of the new drug’s proven effectiveness and safety profile.
Stade de France Pharmacy